Insmed (INSM) Other Non-Current Assets (2011 - 2026)

Insmed's (INSM) quarterly Other Non-Current Assets came in at $99.3 million in Q1 2026, up 10.6% year-on-year from $89.8 million in Q1 2025, and up 1.95% quarter-over-quarter from $97.4 million in Q4 2025.

Insmed (INSM) Other Non-Current Assets (2011 - 2026) Analysis & Trends

Insmed's Other Non-Current Assets history runs 16 years deep, the most recent figure standing at $99.3 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 10.6% year-over-year to $99.3 million in Q1 2026; TTM through Mar 2026 was $99.3 million, a 10.6% increase from a year earlier, with the FY2025 full-year figure at $97.4 million, up 4.45% from the prior year.
  • Other Non-Current Assets advanced to $99.3 million in Q1 2026 per INSM's latest filing, from $97.4 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $99.3 million in Q1 2026 and bottomed at $57.2 million in Q1 2022.
  • The 5-year median for Other Non-Current Assets is $89.8 million (2025), against an average of $85.6 million.
  • Across the five-year window, Other Non-Current Assets jumped 49.25% in 2022 and slipped 6.21% in 2025, its largest moves.
  • Year by year, Other Non-Current Assets stood at $76.1 million in 2022, then gained by 26.9% to $96.6 million in 2023, then slipped by 3.47% to $93.2 million in 2024, then gained by 4.45% to $97.4 million in 2025, then increased by 1.95% to $99.3 million in 2026.
  • Per Business Quant, the three latest INSM Other Non-Current Assets figures stand at $99.3 million (Q1 2026), $97.4 million (Q4 2025), and $91.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Insmed 23.26 Bn 22.03 Bn 258.54 Mn 99.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 99.28 Mn
Dec 31, 2025 97.38 Mn
Sep 30, 2025 91.61 Mn
Jun 30, 2025 88.81 Mn
Mar 31, 2025 89.76 Mn
Dec 31, 2024 93.23 Mn
Sep 30, 2024 96.86 Mn
Jun 30, 2024 85.83 Mn
Mar 31, 2024 95.70 Mn
Dec 31, 2023 96.57 Mn
Sep 30, 2023 92.49 Mn
Jun 30, 2023 83.45 Mn
Mar 31, 2023 81.32 Mn
Dec 31, 2022 76.10 Mn
Sep 30, 2022 63.71 Mn
Jun 30, 2022 66.30 Mn
Mar 31, 2022 57.20 Mn
Dec 31, 2021 50.99 Mn
Sep 30, 2021 47.60 Mn
Jun 30, 2021 49.24 Mn